Qualigen to participate in next funding round for NanoSynex
Market size expected to reach $4.7 billion in 2027 CARLSBAD, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc....
Year: 2025
Invitation to Cosmo’s Unaudited Full Year 2024 Financial Results Webcast on 6 March 2025
Dublin, Ireland--(Newsfile Corp. - January 28, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN: C43) (“Cosmo”) announced today that it will...
Compliancy Group Hosts Annual “Data Breaches and Fines” Webinar
NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Join Compliancy Group for their highly anticipated annual webinar, "Data Breaches and Fines:...
Corti Launches Specialized Healthcare AI Infrastructure, Challenging Industry Misuse of General-Purpose Models
New purpose-built models, inspired by medical residency, tackle rising distractions and "pilot paralysis" from healthcare's increasing reliance on general-purpose AI...
“Longevity Investors Lunch” Held in Davos
Key stakeholders in the longevity field convened at an exclusive Longevity Investors Lunch during the World Economic Forum.Zug, Switzerland--(Newsfile Corp....
Anivive Secures $20 Million Investment from Leonid Capital Partners to Develop the Next Generation of Pet Health
Funding expands manufacturing readiness for Valley fever vaccineThis follows Anivive's $33MM NIAID contract for fungal vaccinesIn total, Anivive has secured...
Sera Prognostics to Host Virtual R&D Day on January 31
Event will showcase results of Company's pivotal PRIME study and include the principal investigator SALT LAKE CITY, Jan. 27, 2025...
Rapid Dose Provides Update on Share Issuance in Debt Settlement with Creditors and Proposed Private Placement
Burlington, Ontario--(Newsfile Corp. - January 27, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced...
Hemostemix Up-lists to TradeGateExchange in Germany
Calgary, Alberta--(Newsfile Corp. - January 27, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...
ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.
TOKYO, Jan. 27, 2025 /PRNewswire/ -- ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments,...
Lucia and Heart Rhythm Society Announce Strategic Collaboration to Enhance UpBeat.org for AFib Patients, Sponsored by the BMS-Pfizer Alliance
SAN DIEGO and WASHINGTON, Jan. 27, 2025 /PRNewswire/ -- Lucia, a leader in health AI and patient engagement solutions, and the...
MediSpend Expands Its Footprint in Governance, Risk and Compliance Solutions with Acquisition of Real Life Sciences
PORTSMOUTH, N.H., Jan. 27, 2025 /PRNewswire/ -- MediSpend, a global technology company providing best-in-class solutions for the life sciences industry,...
Glow LifeTech Announces Appointment of David Côté to Board of Directors
Toronto, Ontario--(Newsfile Corp. - January 27, 2025) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the...
Imperative Care Secures FDA 510(k) Clearance for the Zoom System, Including the First Large-Bore .088” Catheter for Aspiration When Used with the Zoom Catheters, for Stroke Treatment
Final Imperative Trial Data Show the Zoom System Delivered the Fastest Median Case Time in A Well-Controlled, Rigorous Study1CAMPBELL, Calif.--(BUSINESS...
Nine Levers Employers Can Use to Improve Brain Health and Workplace Performance
New unified model developed by UsAgainstAlzheimer's, the Davos Alzheimer's Collaborative and the McKinsey Health Institute provides roadmap for employers to...
Intuitive Announces $45 Million Donation to the Intuitive Foundation to Promote Health and Advance Education
Latest donation brings total contribution to more than $170 millionSUNNYVALE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a...
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
- High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the...
FDA Authorizes Myocene Device for Muscle Fatigue Monitoring and Informed Training Decisions
LIÈGE, Belgium, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Myocene, the Belgian sportstech company specializing in innovative muscle fatigue assessment for...
KFSHRC Heart Centre: A Leader in Advanced Cardiac Treatments
Revolutionizing care from minimally invasive surgery to comprehensive outpatient services RIYADH, Saudi Arabia, Jan. 27, 2025 (GLOBE NEWSWIRE) -- King...
Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT
Study is the first randomized, controlled trial examining a vaccine’s effectiveness in controlling CMV in recipients of HSCT from vaccinated...